AlzeCure Pharma: AlzeCure Gets Late-Breaking Abstract on NeuroRestore ACD856 Clinical Data Accepted to AD/PD 2022 Conference
STOCKHOLM, SWEDEN / ACCESSWIRE / January 18, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
Source: finanznachrichten.de